Government of Alberta Working on Implementing a Provincial Plan to Fund Insulin Pumps for Individuals Living with Type 1 Diabetes
Toronto (January 10,2013) –As part of the 2012 Alberta provincial election, Alison Redford and the Progressive Conservative Party proclaimed their support for an Insulin Pump Program for Albertans living with type 1 diabetes (T1D). JDRF is pleased to see the Government of Alberta working on implementing a provincial plan to fund such an important initiative that affects Albertans living with T1D.
Insulin pump technology provides precise insulin delivery continuously day and night, helping individuals maintain glucose levels between meals, during exercise and overnight. Studies have shown that people living with T1D who use insulin pump therapy experience fewer complications and live longer, healthier lives. In fact, a better managed blood glucose regimen has been proven to reduce the number of heart, kidney and eye-related diabetes complications. By investing in insulin pump therapy in the short-term, we can take steps to lessen or prevent complications from developing later in life, which can result in savings for health care systems in the long-term.
“We applaud Premier Alison Redford and her government for recognizing the importance of insulin pump coverage for Albertans,” said Andrew McKee, President and CEO, JDRF Canada. “JDRF looks forward to working with this government in the coming months to see this positive step put into action for Albertans living with T1D. JDRF Alberta has been actively working on securing Insulin Pump Coverage for all Albertans for the past three years. It has been our longstanding goal to bring Alberta's diabetes support system in-line with coverage offered by most other provinces and territories in Canada, ensuring that individuals living with T1D in Alberta have every opportunity to minimize the long-term complications of this chronic disease,” says McKee.
T1D, the most severe form of diabetes, is a non-preventable autoimmune disease that strikes children and adults suddenly and lasts a lifetime. More than 300,000 Canadians and their families suffer from this disease and are faced with its devastating complications.
Unlike type 2 diabetes, T1D cannot be prevented by diet, exercise or medication. Living with the disease demands constant blood testing and regulating. Someone living with T1D requires approximately 1,500 needles and 2,200 finger-pokes each year to test their blood sugar.
Insulin is not a cure for diabetes, nor does it prevent its eventual complications.
JDRF is the leading global organization focused on type 1 diabetes (T1D) research. Driven by passionate, grassroots volunteers connected to children, adolescents, and adults with this disease, JDRF is now the largest charitable supporter of T1D research. The goal of JDRF research is to improve the lives of all people affected by T1D by accelerating progress on the most promising opportunities for curing, better treating, and preventing T1D. JDRF collaborates with a wide spectrum of partners who share this goal.
Since its founding in 1970 (1974 in Canada), JDRF has awarded more than $1.6 billion (U.S.) to diabetes research. Past JDRF efforts have helped to significantly advance the care of people with this disease, and have expanded the critical scientific understanding of T1D. JDRF will not rest until T1D is fully conquered. For more information, please visit www.jdrf.ca.
For More Information:
Barbara J. Armstrong
Regional Manager, North Central Alberta and Northwest Territories
Regional Manager, Southern Alberta